This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...